SAN DIEGO, Dec. 20, 2010 /PRNewswire-FirstCall/ -- Aethlon Medical, Inc. (OTC Bulletin Board: AEMD), the pioneer in developing therapeutic filtration devices to address infectious disease and cancer, announced today that it will host a presentation for shareholders and other interested parties at 5:30 pm EST on January 12, 2011.
The event will be held at the offices of Fabiani & Company located at 1100 Pennsylvania Avenue, NW, Suite 700, Washington, DC 20004, and is intended to provide investors with access to information presented by the company at the U.S. Department of Health and Human Services BARDA Industry Day in addition to the company's current business and future growth strategies.
As previously announced, the company was selected to present at this prestigious industry event. Please see the company's press release dated December 14, 2010 for further information regarding this presentation.
As seating is limited, please contact Charlene Owen or John Salvador at:Charlene Owen858.459.7800 x email@example.comJohn P. SalvadorDirector, Communications & Investor Relations858.459.7800 firstname.lastname@example.orgAbout Aethlon MedicalAt Aethlon Medical, we create revolutionary devices to address infectious disease and cancer. Our devices are designed to be novel platform solutions that fill therapeutic voids or aid in disease diagnosis and monitoring.
Our Hemopurifier® is the first medical device to selectively target the removal of infectious viruses and immunosuppressive proteins from the entire circulatory system. We recently discovered that our Hemopurifier® captures tumor-secreted exosome
|SOURCE Aethlon Medical, Inc.|
Copyright©2010 PR Newswire.
All rights reserved